Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

Clinical trial NCT00254163 · COMPLETED

Trial details

NCT number: NCT00254163
Sponsor: US Oncology Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

B-Cell Chronic Lymphocytic Leukemia

Start date: 2003-12-01
Primary completion: 2011-09-01
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.